160 related articles for article (PubMed ID: 37487034)
1. How Sweet It Is: A Perspective on the Potential Anti-Tumor Role for SGLT2 Inhibitors.
Gunasekaran D; Shirali AC
Kidney360; 2023 Sep; 4(9):e1322-e1324. PubMed ID: 37487034
[No Abstract] [Full Text] [Related]
2. Diabetes mellitus: Cardiovascular and renal benefits of SGLT2 inhibition: insights from CANVAS.
Vallon V; Thomson SC
Nat Rev Nephrol; 2017 Sep; 13(9):517-518. PubMed ID: 28781373
[No Abstract] [Full Text] [Related]
3. The growing clinical effect of SGLT2 inhibitors.
Del Prato S
Lancet Diabetes Endocrinol; 2023 Apr; 11(4):218-219. PubMed ID: 36878241
[No Abstract] [Full Text] [Related]
4. GLP-1 RA and SGLT2 Inhibitors: In Harmony for Organ Protection.
Aroda VR; Billings LK
J Am Coll Cardiol; 2023 Aug; 82(6):526-528. PubMed ID: 37532423
[No Abstract] [Full Text] [Related]
5. Alleviation of functional iron deficiency by SGLT2 inhibition in patients with type 2 diabetes.
Packer M
Diabetes Obes Metab; 2023 May; 25(5):1143-1146. PubMed ID: 36583283
[No Abstract] [Full Text] [Related]
6. Should We Be Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors in Treating Diabetes?
Packer M
Am J Med; 2018 May; 131(5):461-463. PubMed ID: 29309741
[No Abstract] [Full Text] [Related]
7. Editorial for the
Lymperopoulos A
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069186
[TBL] [Abstract][Full Text] [Related]
8. SGLT2 Inhibitors and Cardiovascular Outcomes: Do they Differ or there is a Class Effect? New Insights from the EMPA-REG OUTCOME trial and the CVD-REAL Study.
Kyriakos G; Quiles-Sanchez LV; Garmpi A; Farmaki P; Kyre K; Savvanis S; Antoniou VK; Memi E
Curr Cardiol Rev; 2020; 16(4):258-265. PubMed ID: 31362691
[TBL] [Abstract][Full Text] [Related]
9. Perioperative Considerations for the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes.
Peacock SC; Lovshin JA; Cherney DZI
Anesth Analg; 2018 Feb; 126(2):699-704. PubMed ID: 28786838
[No Abstract] [Full Text] [Related]
10. SGLT2 inhibitors attenuate alterations of kidney metabolic pathways in youth-onset T2DM.
Carney EF
Nat Rev Nephrol; 2023 Apr; 19(4):213. PubMed ID: 36849740
[No Abstract] [Full Text] [Related]
11. Editorial to the
Lymperopoulos A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108037
[TBL] [Abstract][Full Text] [Related]
12. Expanding the Role of SGLT2 Inhibitors Beyond Diabetes: A Case-Based Approach.
Wong E; Nguyen TV
Sr Care Pharm; 2023 Jun; 38(6):233-238. PubMed ID: 37231576
[TBL] [Abstract][Full Text] [Related]
13. Renal and Cardiac Implications of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors: The State of the Science.
Cruz JE; Ahuja T; Bridgeman MB
Ann Pharmacother; 2018 Dec; 52(12):1238-1249. PubMed ID: 29911393
[TBL] [Abstract][Full Text] [Related]
14. Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitors.
Fender AC; Dobrev D
Naunyn Schmiedebergs Arch Pharmacol; 2023 Apr; 396(4):589-592. PubMed ID: 36943455
[No Abstract] [Full Text] [Related]
15. Sodium-glucose co-transporter 2 inhibition: the saga continues.
Crea F
Eur Heart J; 2022 Nov; 43(41):4215-4218. PubMed ID: 36316017
[No Abstract] [Full Text] [Related]
16. Turning Foes to Friends: Knocking Down Diabetes Associated SGLT2 Transporters and Sustaining Life.
Gupta A; Mittal S; Monika ; Dhingra R; Dhingra N
Curr Diabetes Rev; 2020; 16(7):716-732. PubMed ID: 31951170
[TBL] [Abstract][Full Text] [Related]
17. SGLT2 Inhibitors in Type 2 Diabetes Mellitus.
Ferrannini G; Savarese G; Cosentino F
Heart Fail Clin; 2022 Oct; 18(4):551-559. PubMed ID: 36216485
[TBL] [Abstract][Full Text] [Related]
18. SGLT2 Inhibitors and Kidney Diseases: A Clinical Perspective.
Theofilis P; Kalaitzidis RG
Curr Med Chem; 2023; 30(23):2595-2603. PubMed ID: 36578262
[No Abstract] [Full Text] [Related]
19. Emerging roles of Sodium-glucose cotransporter 2 inhibitors in Diabetic kidney disease.
Gan T; Song Y; Guo F; Qin G
Mol Biol Rep; 2022 Nov; 49(11):10915-10924. PubMed ID: 36002651
[TBL] [Abstract][Full Text] [Related]
20. Treatment of diabetes mellitus in patients with chronic hepatitis B: Are SGLT2 inhibitors hitting the sweet spot?
Sonneveld MJ; Brouwer WP; Janssen HLA
Hepatology; 2023 Nov; 78(5):1334-1336. PubMed ID: 37185255
[No Abstract] [Full Text] [Related]
[Next] [New Search]
